Russell Merritt is a Gastroenterology physician affiliated with Children's Hospital of Los Angeles. OpenAlex indexes 100 publications with 2,804 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4650 W Sunset Blvd
Ms #78
Los Angeles, CA 900276062
Telephone
323-361-5704Registry record last updated 3 Jun 2008.
Clinical trials
- Infant & Toddler Short Gut Feeding Outcomes Study
Sponsor: Children's Hospital Los Angeles
- Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Sponsor: Children's Hospital Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
100%Nonsteroidal Anti-inflammatory Drug100%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper
Journal of Pediatric Gastroenterology and Nutrition
2020 - Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome–Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies
Journal of Parenteral and Enteral Nutrition
2020 - Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study
Journal of Parenteral and Enteral Nutrition
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Kevin Lemley, MD
Children's Hospital of Los Angeles
Floyd Gilles, MD
Children's Hospital of Los Angeles
Ryan Handoko, MD
Children's Hospital of Los Angeles
Robert Venick, MD
Children's Hospital of Los Angeles
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”